ATE123287T1 - Kaffeinsaure-derivate,oraposid,ihre kosmetische oder pharmazeutische zusammensetzungen,insbesondere mit dermatologischer wirkung. - Google Patents

Kaffeinsaure-derivate,oraposid,ihre kosmetische oder pharmazeutische zusammensetzungen,insbesondere mit dermatologischer wirkung.

Info

Publication number
ATE123287T1
ATE123287T1 AT91907075T AT91907075T ATE123287T1 AT E123287 T1 ATE123287 T1 AT E123287T1 AT 91907075 T AT91907075 T AT 91907075T AT 91907075 T AT91907075 T AT 91907075T AT E123287 T1 ATE123287 T1 AT E123287T1
Authority
AT
Austria
Prior art keywords
pct
oraposide
cosmetic
pharmaceutical compositions
caffeic acid
Prior art date
Application number
AT91907075T
Other languages
English (en)
Inventor
Claude Andary
Patrice Andre
Original Assignee
Dior Christian Parfums
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dior Christian Parfums filed Critical Dior Christian Parfums
Application granted granted Critical
Publication of ATE123287T1 publication Critical patent/ATE123287T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/18—Acyclic radicals, substituted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/004—Aftersun preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Communicable Diseases (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Botany (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT91907075T 1991-03-21 1991-03-21 Kaffeinsaure-derivate,oraposid,ihre kosmetische oder pharmazeutische zusammensetzungen,insbesondere mit dermatologischer wirkung. ATE123287T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/FR1991/000229 WO1992016544A1 (fr) 1991-03-21 1991-03-21 Nouveau derive de l'acide cafeique, l'oraposide, composition cosmetique ou pharmaceutique, notamment dermatologique le contenant

Publications (1)

Publication Number Publication Date
ATE123287T1 true ATE123287T1 (de) 1995-06-15

Family

ID=34834297

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91907075T ATE123287T1 (de) 1991-03-21 1991-03-21 Kaffeinsaure-derivate,oraposid,ihre kosmetische oder pharmazeutische zusammensetzungen,insbesondere mit dermatologischer wirkung.

Country Status (10)

Country Link
US (1) US5719129A (de)
EP (1) EP0576420B1 (de)
JP (1) JP3147900B2 (de)
KR (1) KR100194830B1 (de)
AT (1) ATE123287T1 (de)
AU (1) AU670742B2 (de)
CA (1) CA2102689A1 (de)
DE (1) DE69110136T2 (de)
ES (1) ES2075437T3 (de)
WO (1) WO1992016544A1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4444238A1 (de) * 1994-12-13 1996-06-20 Beiersdorf Ag Kosmetische oder dermatologische Wirkstoffkombinationen aus Zimtsäurederivaten und Flavonglycosiden
DE19615575A1 (de) * 1996-04-19 1997-10-23 Beiersdorf Ag Verwendung von Glucosiden und Ferulasäure als antiirritativer Wirkstoff in kosmetischen und topischen dermatologischen Zubereitungen
AU6473898A (en) * 1997-03-21 1998-10-20 Regents Of The University Of California, The Methods for modulating neurotrophic factor-associated activity using aldose reductase inhibitors
US6696407B1 (en) 1997-03-21 2004-02-24 The Regents Of The University Of California Huntington's disease treatment comprising administering aldose reductase inhibitors to increase striatal CNTF
US6679584B2 (en) * 1997-07-15 2004-01-20 Silverbrook Research Pty Ltd. High volume pagewidth printing
US8466109B2 (en) * 1998-10-05 2013-06-18 Laboratoires Expanscience Cosmetic method for preventing and/or treating skin stretchmarks, and use in dermatology
US8404257B1 (en) * 1998-11-02 2013-03-26 Basf Se Stabilisation of body-care and household products
US20040228816A1 (en) * 1998-12-30 2004-11-18 Carine Nizard Cosmetic or dermatological composition containing an active agent which stimulates synthesis of the protein HSP 32 in the skin
FR2787996B1 (fr) * 1998-12-30 2002-05-10 Dior Christian Parfums Composition cosmetique ou dermatologique contenant un actif stimulant la synthese de la proteine hsp 32 dans la peau et methode de traitement cosmetique
IT1317732B1 (it) * 2000-01-20 2003-07-15 Giuliani Spa Composti ad attivita' antiossidante, composizioni utili qualiintegratori alimentari che li contengono e procedimento per
AU2000258901A1 (en) 2000-04-06 2001-10-23 Nicholas V. Perricone Treatment of skin damage using olive oil polyphenols
EP1166765A3 (de) * 2000-06-20 2002-05-02 Laboratoires Serobiologiques Verfahren zum Schutz der menschlichen Haut
EP1315691B2 (de) * 2000-09-01 2017-09-13 Creagri, Inc. Verfahren zur gewinnung einer hydroxytyrosolreichen zusammensetzung aus pflanzenwasser
US7713569B2 (en) 2000-09-01 2010-05-11 Creagri, Inc. Hydroxytyrosol-rich composition from olive vegetation water and method of use thereof
EP1260212A1 (de) * 2001-05-21 2002-11-27 Cognis France S.A. Kosmetische Mittel
JP2002363075A (ja) * 2001-06-05 2002-12-18 Kao Corp 高血圧症予防・治療剤
WO2003068171A2 (en) * 2002-02-13 2003-08-21 Creagri, Inc. Method and composition for treatment of inflammation and aids-associated neurological disorders
DE10215055A1 (de) * 2002-04-03 2003-10-30 Univ Schiller Jena Verwendung von Kaffeesäureestern zur Herstellung von kosmetischen nutrazeutischen sowie pharmazeutischen Präparaten und Arzneimitteln
US6989162B2 (en) * 2003-03-31 2006-01-24 Council Of Scientific & Industrial Research Hepatoprotective agent of plant origin and a process thereof
JP4486508B2 (ja) * 2003-03-31 2010-06-23 カウンセル オブ サイエンティフィック アンド インダストリアル リサーチ Ｃｏｌｅｒｂｒｏｏｋｅａｏｐｐｏｓｉｔｉｆｏｌｉａからの肝保護剤アクテオシドの単離
US20060020029A1 (en) * 2004-07-02 2006-01-26 Shimasaki Craig D Pharmaceutical compositions from ethnobotanicals
WO2006020588A1 (en) * 2004-08-09 2006-02-23 Creagri, Inc. Olive compositions and methods for treating inflammatory conditions
US9789149B2 (en) * 2005-07-19 2017-10-17 Creagri, Inc. Vegetation water composition for treatment of inflammatory skin conditions
FR2892923B1 (fr) * 2005-11-08 2009-01-16 Engelhard Lyon Sa Utilisatiion des derives de l'acide para-coumarique ou para- hydroxycinnamique dans des compositions cosmetiques ou dermatologiques.
WO2008083389A1 (en) * 2006-12-29 2008-07-10 Moleculin, L.L.C. Methods of treating skin disorders with caffeic acid analogs
WO2008093678A1 (ja) * 2007-01-29 2008-08-07 Oryza Oil & Fat Chemical Co., Ltd. ヒアルロニダーゼ阻害剤
JP2009263279A (ja) * 2008-04-25 2009-11-12 Oriza Yuka Kk エラスターゼ阻害剤
US8450337B2 (en) * 2008-09-30 2013-05-28 Moleculin, Llc Methods of treating skin disorders with caffeic acid analogs
WO2012143017A1 (en) 2011-04-17 2012-10-26 El-Sawy Mohamed Fakhr El-Din The use of orobancheace extract for the treatment of hepatitis c virus and nonalcoholic fatty liver disease
GB201705403D0 (en) * 2017-04-04 2017-05-17 Givaudan Sa Improvements in or relating to organic compounds
CN109776633B (zh) * 2019-03-18 2020-08-04 暨南大学 一种苯丙素类化合物及其制备方法与应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2302745A1 (fr) * 1975-03-07 1976-10-01 Screen Esters heterosidiques d'acide cafeique, leurs procedes de preparation e
FR2314725A1 (fr) * 1975-03-07 1977-01-14 Screen Procede pour la preparation d'heterosides de dihydroxyphenylalcanol et medicaments contenant de tels heterosides
FR2652086B1 (fr) * 1989-09-20 1993-05-21 Andary Claude Compose nouveau d'origine vegetale, derive de l'acide cafeique, l'oraposide; composition a usage therapeutique et composition dermato-cosmetique le contenant.

Also Published As

Publication number Publication date
CA2102689A1 (fr) 1992-09-22
WO1992016544A1 (fr) 1992-10-01
EP0576420A1 (de) 1994-01-05
AU670742B2 (en) 1996-08-01
JPH06508601A (ja) 1994-09-29
US5719129A (en) 1998-02-17
DE69110136D1 (de) 1995-07-06
ES2075437T3 (es) 1995-10-01
KR100194830B1 (ko) 1999-06-15
AU7585091A (en) 1992-10-21
DE69110136T2 (de) 1996-01-11
JP3147900B2 (ja) 2001-03-19
EP0576420B1 (de) 1995-05-31

Similar Documents

Publication Publication Date Title
ATE123287T1 (de) Kaffeinsaure-derivate,oraposid,ihre kosmetische oder pharmazeutische zusammensetzungen,insbesondere mit dermatologischer wirkung.
ES2069388T3 (es) Derivados s-triazinicos que llevan sustituyentes benzalmalonatos, su procedimiento de preparacion, composiciones cosmeticas filtrantes que los contienen, y su empleo para proteger la piel y los cabellos de las radiaciones ultravioleta.
ES2113416T3 (es) Derivados s-triazinicos que llevan sustituyentes benciliden-alcanfor, su procedimiento de preparacion, composiciones cosmeticas filtrantes que los contienen y su utilizacion para proteger la piel y los cabellos de la radiacion ultravioleta.
DK0513104T3 (da) Anvendelse af et alfa-tocopherolphosphat eller et af dets derivater til fremstilling af kosmetiske, dermatologiske eller farmaceutiske præparater, og således opnåede præparater
MX9400206A (es) Derivados de vinil-azaindol, proceso para su preparacion y composiciones farmaceuticas que los contienen.
BR9916790A (pt) Uso de um composto, composto, processo para amanufatura do mesmo, composição farmacêtica, e,método para produzir um efeito de dano vascularem um animal de sangue quente
DE69206214T2 (de) Neue Arylethylaminderivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen.
HUP0002348A2 (hu) A bőr mesterséges színezésére szolgáló szantalinokat vagy szantarubinokat tartalmazó kozmetikai készítmények
ES2098004T3 (es) Peptidos derivados de trifluoro-metil-cetonas con una actividad inhibidora de la elastasa leucocitaria humana (hle), su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
BR9913592A (pt) Compostos, processo de preparação dos compostos, e, composições farmacêuticas
DE3785136T2 (de) Arzneimittel zur inhibition von hautfalte.
DK0526302T3 (da) Præparat til depigmenterende virkning på basis af derivater af (2,5-dihydroxyphenyl)-carboxylsyre
KR930012008A (ko) 활성 산소 소거제
ES2104090T3 (es) Nuevas 3',5'-di-t-butil-4'-hidroxi-flavonas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
DE3764885D1 (de) Neue 5-alkoxy-2,4-diamino-alkylbenzole sowie haarfaerbemittel mit 5-alkoxy-2,4-diamino-alkyl-benzolen.
SE8000131L (sv) Kompositioner for anvendning som kosmetiska medel samt ett forfarande for framstellning av de aktiva komponenterna deri
FI935350A (fi) Transdermala farmaceutiska kompositioner innehaollande 4-substituerade imidazoler
ES2133511T3 (es) Composicion tintorea que contiene p-fenilendiaminas con azufre, p-fenilendiaminas con azufre y su procedimiento de preparacion.
AR007052A1 (es) Un derivado de carbohidrato, su uso y una composicion farmaceutica que lo comprende
TNSN93107A1 (fr) Derives de piperidine, leur preparation et leur application en therapeutique
ES2069719T3 (es) Nuevos derivados de tiofeno, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
DE69413831T2 (de) Phenoxyphenylcyclopentenyl-hydroxyharnstoffe
ATE121726T1 (de) Hydroquinonester von aminosäuren, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische oder kosmetische zusammensetzungen.
FI925618A0 (fi) Etanoladdukter av 6-sulfonylsubstituerade 3-hydroxikromaner och deras anvaendning som inhalationsmedel vid sjukdomar
NO933691D0 (no) Tiokarbamatsulfoksydsammensetning for avholdenhet fra inntakelse av alkohol